Physician profile
Ana Cecilia Loza
NPI 1932851631
$3,166.82
in general payments reported to CMS, 2019-2025
12 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,826 · 2024: $123 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,166.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $2,347.67 | 2023 | V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo |
| Hollister Incorporated | $152.38 | 2023 | New Image, Premier |
| Sk Life Science, INC. | $124.97 | 2023 | Xcopri |
| Gilead Sciences, INC. | $121.85 | 2025 | Epclusa |
| Convatec INC. | $110.74 | 2023 | |
| Hydrofera LLC | $91.16 | 2024-2025 | Hydrofera Blue |
| Smith+Nephew, INC. | $90.10 | 2023 | Collagenase Santyl |
| Abbvie INC. | $37.67 | 2024 | |
| Cipher Pharmaceuticals US LLC | $32.47 | 2025 | Spinosad, Natroba |
| Urgo Medical North America, LLC | $25.49 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Exact Sciences Corporation | $17.63 | 2025 | Cologuard Collection Kit |
| Hartmann USA, INC. | $14.69 | 2025 | Zetuvit Plus 10x10 P10 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Loza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.